Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive fluoxetine improves global function in chronic schizophrenia.

M B Goldman1, H M Janecek

  • 1Elgin Mental Health Center, Illinois.

The Journal of Neuropsychiatry and Clinical Neurosciences
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients.

Hippocampus·2007
Same author

Reliability of serial urine HCG as a biomarker to detect early pregnancy loss.

Human reproduction (Oxford, England)·2002
Same author

Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors.

Radiation research·2001
Same author

The silent consumer: women's reports and ratings of abortion services.

Medical care·2001
Same author

Anemia and deficiencies of folate and vitamin B-6 are common and vary with season in Chinese women of childbearing age.

The Journal of nutrition·2000
Same author

Chromosomal aberrations and hprt mutant frequencies in long-term American thorotrast survivors.

International journal of radiation biology·2000
Same journal

The Neuropsychiatric Phenotype of Klüver-Bucy Syndrome: A Systematic Review of Reported Cases.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Diffusion Tensor Imaging Correlates of Financial Capacity Instrument-Short Form Completion Time in Mild Cognitive Impairment.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

A 3-Week Intensive Outpatient Program for Patients With Persistent Neuropsychiatric Symptoms After Remote TBI.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Outcomes of Integrated Practice Unit Treatment for Mild Traumatic Brain Injury and Co-occurring Conditions Among Veterans.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Rates of Comorbid Psychiatric Conditions Among Adults With Hydrocephalus at a Hydrocephalus Specialty Center.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Relationships Among Dementia, Parental Death, and Other Adverse Childhood Experiences: Systematic Review and Meta-Analysis.

The Journal of neuropsychiatry and clinical neurosciences·2026
See all related articles

Adjunctive fluoxetine improved clinical status in chronic schizophrenia patients. This open trial showed reduced violence and increased program participation and socialization.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuropharmacology

Background:

  • Schizophrenia is a chronic mental disorder with significant impact on patient functioning.
  • Adjunctive treatments are explored to improve outcomes in schizophrenia.
  • Fluoxetine is a selective serotonin reuptake inhibitor with potential psychotropic effects.

Purpose of the Study:

  • To evaluate the efficacy of adjunctive fluoxetine in chronic schizophrenic inpatients.
  • To assess changes in clinical state, aggression, and social behavior.

Main Methods:

  • Open-label clinical trial design.
  • Eight chronic schizophrenic inpatients were included.
  • Patients received fluoxetine 20 mg/day for a mean of 10.6 weeks.

Related Experiment Videos

Main Results:

  • All patients demonstrated improvement in overall clinical state.
  • A decrease in violent incidents was observed.
  • Increased participation in therapeutic programs and socialization was noted.

Conclusions:

  • Adjunctive fluoxetine appears beneficial for chronic schizophrenic inpatients.
  • Fluoxetine may help reduce aggression and improve social functioning in this population.
  • Further controlled studies are warranted to confirm these findings.